NVR CVI (Tekturna HCT 300 mg-12.5 mg)
Generic Name: aliskiren/hydrochlorothiazide
Pill imprint NVR CVI has been identified as Tekturna HCT 300 mg-12.5 mg.
Tekturna HCT is used in the treatment of high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Tekturna HCT 300 mg-12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- aliskiren/hydrochlorothiazide
- Imprint:
- NVR CVI
- Strength:
- 300 mg-12.5 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0523
- Inactive Ingredients:
- silicon dioxide
crospovidone
hypromelloses
ferric oxide red
lactose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
povidone
magnesium silicate
titanium dioxide
wheat starch
More about Tekturna HCT (aliskiren / hydrochlorothiazide)
Consumer resources
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
